Transmission of Mycobacterium tuberculosis from medical waste

被引:40
作者
Johnson, KR
Braden, CR
Cairns, KL
Field, KW
Colombel, AC
Yang, ZH
Woodley, CL
Morlock, GP
Weber, AM
Boudreau, AY
Bell, TA
Onorato, IM
Valway, SE
Stehr-Green, PA
机构
[1] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA
[3] Ctr Dis Control & Prevent, Div AIDS STD & TB Lab Res, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
[4] Washington State Dept Hlth, Olympia, WA USA
[5] Washington State Dept Hlth, Seattle, WA USA
[6] Cent Arkansas Vet Hlth Care Syst, Little Rock, AR USA
[7] NIOSH, Hazard Evaluat & Tech Assistance Branch, Div Surveillance Hazard Evaluat & Field Studies, Atlanta, GA USA
[8] NIOSH, Hazard Evaluat & Tech Assistance Branch, Div Surveillance Hazard Evaluat & Field Studies, Denver, CO USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2000年 / 284卷 / 13期
关键词
D O I
10.1001/jama.284.13.1683
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Washington State has a relatively low incidence rate of tuberculosis (TB) infection. However, from May to September 1997, 3 cases of pulmonary TB were reported among medical waste treatment workers at 1 facility in Washington. There is no previous documentation of Mycobacterium tuberculosis transmission as a result of processing medical waste. Objective To identify the source(s) of these 3 TB infections. Design, Setting, and Participants Interviews of the 3 infected patient-workers and their contacts, review of patient-worker medical records and the state TB registry, and collection of all multidrug-resistant TB (MDR-TB) isolates identified after January 1, 1995, from the facility's catchment area; DNA fingerprinting of all isolates; polymerase chain reaction and automated DNA sequencing to determine genetic mutations associated with drug resistance; and occupational safety and environmental evaluations of the facility. Main Outcome Measures Previous exposures of patient-workers to TB; verification of patient-worker tuberculin skin test histories; identification of other cases of TB in the community and at the facility; drug susceptibility of patient-worker isolates; and potential for worker exposure to live M tuberculosis cultures. Results All 3 patient-workers were younger than 55 years, were born in the United States, and reported no known exposures to TB. We did not identify other TB cases. The 3 patient-workers' isolates had different DNA fingerprints. One of 10 MDR-TB catchment-area isolates matched an MDR-TB patient-worker isolate by DNA fingerprint pattern, DNA sequencing demonstrated the same rare mutation in these isolates. There was no evidence of personal contact between these 2 individuals. The laboratory that initially processed the matching isolate sent contaminated waste to the treatment facility. The facility accepted contaminated medical waste where it was shredded, blown, compacted, and finally deactivated. Equipment failures, insufficient employee training, and respiratory protective equipment inadequacies were identified at the facility. Conclusion Processing contaminated medical waste resulted in transmission of M tuberculosis to at least 1 medical waste treatment facility worker.
引用
收藏
页码:1683 / 1688
页数:6
相关论文
共 25 条
[1]   Transmission of a highly drug-resistant strain (strain W1) of Mycobacterium tuberculosis - Community outbreak and nosocomial transmission via a contaminated bronchoscope [J].
Agerton, T ;
Valway, S ;
Gore, B ;
Pozsik, C ;
Plikaytis, B ;
Woodley, C ;
Onorato, I .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (13) :1073-1077
[2]  
BASS JB, 1990, AM REV RESPIR DIS, V142, P725
[3]   Retrospective detection of laboratory cross-contamination of Mycobacterium tuberculosis cultures with use of DNA fingerprint analysis [J].
Braden, CR ;
Templeton, GL ;
Stead, WW ;
Bates, JH ;
Cave, MD ;
Valway, SE .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (01) :35-40
[4]  
CAIRNS KL, 1999, P N AM REG INT UN TB
[5]  
*CDCP, 1993, DHHS PUBL
[6]  
*CDCP, 1998, 9800272709 NIOSH CTR
[7]  
*CDCP, 1995, MMWR-MORBID MORTAL W, V44, P19
[8]  
*CDCP, 1998, REP TUB US 1997, P9
[9]  
Dean A.G, 1995, EPI INFO VERSION 6 W
[10]  
EMERY R, 1992, AM IND HYG ASSOC J, V53, P339, DOI 10.1202/0002-8894(1992)053<0339:ROBADI>2.0.CO